NSTEMI
non-ST elevation myocardial infarction

They also improve symptoms of cardiac ischemia in NSTEMI.

In the absence of such changes, it is not possible to immediately distinguish between unstable angina and NSTEMI.

Morphine was classically used if nitroglycerin was not effective; however, it may increase mortality in the setting of NSTEMI.

The patient may still have suffered a "non-ST elevation MI" (NSTEMI).

However, NSTEMI had significantly more "major cardiac events" (death, myocardial infarction, disabling stroke, or requiring revascularization) at one year (24.0% vs 16.6%).

If there is evidence of damage (infarction), the chest pain is attributed to a "non-ST elevation MI" (NSTEMI).

Depending on the risk assessment, stress testing or angiography may be used to identify and treat coronary artery disease in patients who have had an NSTEMI or unstable angina.

Thrombolytic drugs are contraindicated for the treatment of unstable angina and NSTEMI and for the treatment of individuals with evidence of cardiogenic shock.

Non-ST elevation myocardial infarction (NSTEMI) may be managed with medication, although PCI may be required if the patient's risk warrants it.

Individuals without ST segment elevation are presumed to be experiencing either unstable angina (UA) or non-ST segment elevation myocardial infarction (NSTEMI).

Non-ST segment elevation myocardial infarction (NSTEMI) or "non-Q-wave MI": This heart attack, or MI, does not cause typical changes on an electrocardiogram (ECG).

Unstable angina, STEMI and NSTEMI are attributed to "plaque rupture", where one of the plaques gets weakened, develops a tear, and forms an adherent thrombus that either obstructs blood flow or floats further down the blood vessel, causing obstruction there.

In a cohort study comparing NSTEMI and STEMI, patients with NSTEMI had statistically similar mortality at one year after PCI as compared to patients with STEMI (3.4% vs 4.4%).